Literature DB >> 31073162

An 11-year analysis of microbial keratitis in the South West of England using brain-heart infusion broth.

Shokufeh Tavassoli1, Gayathri Nayar2, Kieren Darcy3, Mariusz Grzeda3, Jon Luck4, O Martin Williams2, Derek Tole3.   

Abstract

BACKGROUND: The aims of this study were to identify the organisms responsible for microbial keratitis, as identified by corneal scrape using brain-heart infusion broth, trends over time and antimicrobial sensitivities, over an 11-year period at two eye units in the South West of England; Bristol Eye Hospital and Royal United Hospital, Bath.
METHODS: All corneal scrapes performed and sent for microbiological analysis between 4th April 2006 and 31st October 2017 at the two eye units were retrospectively reviewed. First-line treatment was monotherapy with levofloxacin 0.5% and second-line treatment was a combination of cefuroxime 5% and gentamicin 1.5%. Both direct and enrichment cultures were used.
RESULTS: In total, 2614 corneal scrapes from 2116 patients (1082 female, mean age 47.7 ± 21.2 years) were identified. 38.1% (n = 996) were culture positive and 1195 organisms were cultured. In all, 91.6% were bacteria (69.4% were gram-positive, 30.6% gram-negative). Coagulase-negative Staphylococci (CoNS) were the most commonly cultured organism (n = 430). Pseudomonas aeruginosa was the most commonly identified gram-negative organism (n = 189). In total, 6.9% (n = 83) of organisms cultured were fungi. In all, 1.4% (n = 17) were acanthamoeba. There was no statistically significant trend in the organisms observed over the study period. Sensitivity testing confirmed reasonable sensitivity to the empiric antibiotics used in clinical practice.
CONCLUSIONS: This is the first report on microbial keratitis trends in the South West of England. Virulent organisms were likely to be detected on direct culture, whereas low virulent organisms such as CoNS were more likely to be detected on enrichment alone. Antibiotic sensitivity testing confirmed fluoroquinolone monotherapy as appropriate first-line treatment.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31073162      PMCID: PMC7002735          DOI: 10.1038/s41433-019-0463-6

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  11 in total

1.  Impact of the COVID-19 Pandemic on the Incidence and Characteristics of Culture-Positive Microbial Keratitis at a Tertiary Eye Hospital in the UK.

Authors:  Luke Michaels; Jay Richardson; Andrew Walkden; Fiona Carley
Journal:  Clin Ophthalmol       Date:  2022-08-10

Review 2.  Potential new fluoroquinolone treatments for suspected bacterial keratitis.

Authors:  Rose Herbert; Mary Caddick; Tobi Somerville; Keri McLean; Shakeel Herwitker; Timothy Neal; Gabriela Czanner; Stephen Tuft; Stephen B Kaye
Journal:  BMJ Open Ophthalmol       Date:  2022-07

3.  Risk Factors, Clinical Outcomes, and Prognostic Factors of Bacterial Keratitis: The Nottingham Infectious Keratitis Study.

Authors:  Darren Shu Jeng Ting; Jessica Cairns; Bhavesh P Gopal; Charlotte Shan Ho; Lazar Krstic; Ahmad Elsahn; Michelle Lister; Dalia G Said; Harminder S Dua
Journal:  Front Med (Lausanne)       Date:  2021-08-11

Review 4.  Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance.

Authors:  Darren Shu Jeng Ting; Charlotte Shan Ho; Rashmi Deshmukh; Dalia G Said; Harminder S Dua
Journal:  Eye (Lond)       Date:  2021-01-07       Impact factor: 3.775

5.  12-year analysis of incidence, microbiological profiles and in vitro antimicrobial susceptibility of infectious keratitis: the Nottingham Infectious Keratitis Study.

Authors:  Darren Shu Jeng Ting; Charlotte Shan Ho; Jessica Cairns; Ahmad Elsahn; Mouhamed Al-Aqaba; Tim Boswell; Dalia G Said; Harminder Singh Dua
Journal:  Br J Ophthalmol       Date:  2020-06-24       Impact factor: 4.638

Review 6.  Mycotic Keratitis-A Global Threat from the Filamentous Fungi.

Authors:  Jeremy J Hoffman; Matthew J Burton; Astrid Leck
Journal:  J Fungi (Basel)       Date:  2021-04-03

7.  Clinical Characteristics and Outcomes of Fungal Keratitis in the United Kingdom 2011-2020: A 10-Year Study.

Authors:  Darren Shu Jeng Ting; Mohamed Galal; Bina Kulkarni; Mohamed S Elalfy; Damian Lake; Samer Hamada; Dalia G Said; Harminder S Dua
Journal:  J Fungi (Basel)       Date:  2021-11-12

Review 8.  Diagnostic armamentarium of infectious keratitis: A comprehensive review.

Authors:  Darren S J Ting; Bhavesh P Gopal; Rashmi Deshmukh; Gerami D Seitzman; Dalia G Said; Harminder S Dua
Journal:  Ocul Surf       Date:  2021-11-13       Impact factor: 5.033

9.  An Evaluation of a Simplified Impression Membrane Sampling Method for the Diagnosis of Microbial Keratitis.

Authors:  Tobi F Somerville; Rose Herbert; Timothy Neal; Malcolm Horsburgh; Stephen B Kaye
Journal:  J Clin Med       Date:  2021-11-30       Impact factor: 4.241

10.  Hybrid derivative of cathelicidin and human beta defensin-2 against Gram-positive bacteria: A novel approach for the treatment of bacterial keratitis.

Authors:  Imran Mohammed; Harminder S Dua; Darren Shu Jeng Ting; Eunice Tze Leng Goh; Venkatesh Mayandi; Joanna M F Busoy; Thet Tun Aung; Mercy Halleluyah Periayah; Mario Nubile; Leonardo Mastropasqua; Dalia G Said; Hla M Htoon; Veluchamy Amutha Barathi; Roger W Beuerman; Rajamani Lakshminarayanan
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.